Revised and expanded for the third edition, this text describes the documentation required to minimize the chances of regulatory citations. It blends fundamental theory and practical advice on drug product stability in scientific, technical and regulatory environments. The book also covers developments in indicating assays, computer use, clinical trial materials, strategic planning and packaging.